The proliferation of false medicines represents a deeply concerning challenge facing the global public health landscape. These fraudulent products, often mimicking legitimate medications, pose a significant danger to individual safety, undermining care effectiveness and potentially leading to severe adverse health outcomes. Motivated by substantial